Alnylam Pharmaceuticals
ALNY
#448
Rank
A$78.91 B
Marketcap
A$597.35
Share price
0.50%
Change (1 day)
53.82%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: A$732.31 AUD on 2025-10-20

Lowest end of day price: A$5.89 AUD on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2025

Annual Stock Price Performance

Year Performance
2025 71.51%
2024 20.72%
2023-18.06%
2022 36.65%
2021 32.38%
2020 12.41%
2019 58.29%
2018-44.70%
2017 228.80%
2016-59.75%
2015-3.71%
2014 51.89%
2013 235.42%
2012 110.74%
2011-18.58%
2010-45.64%
2009-29.94%
2008-14.49%
2007 34.82%
2006 65.12%
2005 75.73%
2004 6.71%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
A$104.52 0.40%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1,168-0.19%๐Ÿ‡บ๐Ÿ‡ธ USA
A$33.27 1.45%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.94-0.76%๐Ÿ‡บ๐Ÿ‡ธ USA
A$12.16 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA
A$207.04-0.18%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$72.10 0.08%๐Ÿ‡ซ๐Ÿ‡ท France
A$47.32 0.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel